Xeroderma pigmentosum is a rare autosomal recessive genodermatosis that affects about 1 per million in the United States, and the incidence in Japan is much higher at 45 per million. The incidence in Western Europe is estimated to be 2.3 cases per million. Cases of XP have also appeared in North Africa and the Middle East.

Most patients present in the first few years of life with severe sun sensitivity and after developing severe sunburns despite minimal sun exposure. Infants may develop erythema and bullae in sun-exposed areas. Patients typically present with ephelides and other pigmentary changes before the age of two. The median age for the development of their first non-melanoma skin cancer is about nine, and the median age for the development of their first malignant melanoma is about 22.